Should Relaxed Methadone Rules Continue After the Pandemic Ends?
The authors propose evaluating which aspects of previous policy and practices for OUD should resume and which aspects of current policy and practice exemptions should continue.
Opioids
Opioid Analgesic Approvals Based on Limited Data, Study Says
Opioid products approved by the FDA between 1997 and 2018 relied on short- or intermediate-term studies that did not adequately analyze safety outcomes.
Prenatal Exposure to OMT Does Not Worsen Neonatal Outcomes
Growth parameters similar to those for newborns of women with opioid use disorders during pregnancy
Benzodiazepines: Primary Care’s New Drug Problem
Curtailing prescription opioid use has led to an increase in prescribing benzodiazepines to manage pain.
Recent Increase Reported in Drug Overdose Deaths Involving Fentanyl
Numbers and rates increased for all sex, age, racial and ethnic subgroups, most public health regions
Tramadol as First-Line Therapy for OA May Be Associated With Greater Mortality
Treating osteoarthritis in older patients with tramadol vs nonsteroidal anti-inflammatory drugs may be associated with an increased mortality rate during the year following treatment initiation.
Generic Versions of Suboxone Sublingual Film Now Available to Treat Opioid Dependence
Generic versions of Suboxone (buprenorphine and naloxone; Indivior) Sublingual Film have been made available by Sandoz and Alvogen.
reSET-O Digital Therapeutic for Opioid Use Disorder Now Available
Sandoz and Pear Therapeutics announced the launch of reSET-O, a new digital therapeutic for patients aged ≥18 years with opioid use disorder (OUD) currently under clinician care.
Opioid-Induced Constipation Management Guidelines
Recommendations from the American Gastroenterological Association (AGA) for the medical management of opioid-induced constipation (OIC).
FDA Advisory Panels: Prescribe Naloxone With Opioid Painkillers
The labels of prescription opioid painkillers should advise doctors to consider simultaneously prescribing the opioid overdose antidote naloxone, 2 US Food and Drug Administration advisory panels recommend.
